Bretagne, Stéphane

Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)

Lortholary, O., Gangneux, J.-P., Sitbon, K., Lebeau, B., de Monbrison, F., Le Strat, Y., Coignard, B., Dromer, F., & Bretagne, S. (2011) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 331

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients

Marchetti, O., Lamoth, F., Mikulska, M., Viscoli, C., Verweij, P., Bretagne, S., & Groups, A. T. E. C. O. I. I. L. (. L. W. (2012) · Bone Marrow Transplantation

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 275

Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing

White, P. L., Wingard, J. R., Bretagne, S., Löffler, J., Patterson, T. F., Slavin, M. A., Barnes, R. A., Pappas, P. G., & Donnelly, J. P. (2015) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 193

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

Hoenigl, M., Salmanton-García, J., Egger, M., Gangneux, J.-P., Bicanic, T., Arikan-Akdagli, S., Alastruey-Izquierdo, A., Klimko, N., Barac, A., Özenci, V., et al. (2023) · The Lancet Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 152

Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative

White, P. L., Barnes, R. A., Springer, J., Klingspor, L., Cuenca-Estrella, M., Morton, C. O., Lagrou, K., Bretagne, S., Melchers, W. J. G., Mengoli, C., et al. (2015) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 140

Candida spp. with Acquired Echinocandin Resistance, France, 2004–20101

Dannaoui, E., Desnos-Ollivier, M., Garcia-Hermoso, D., Grenouillet, F., Cassaing, S., Baixench, M.-T., Bretagne, S., Dromer, F., Lortholary, O., & the French Mycoses Study Group (2012) · Emerging infectious diseases

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 130

In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection

Colley, T., Alanio, A., Kelly, S. L., Sehra, G., Kizawa, Y., Warrilow, A. G. S., Parker, J. E., Kelly, D. E., Kimura, G., Anderson-Dring, L., et al. (2017) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 87

Fluconazole and Echinocandin resistance of Candida glabrata correlates better with antifungal drug exposure rather than with MSH2 mutator genotype in a French Cohort of patients harboring low rates of resistance.

Dellière, S., Healey, K., Gits-Muselli, M., Carrara, B., Barbaro, A., Guigue, N., Lecefel, C., Touratier, S., Desnos-Ollivier, M., Perlin, D. S., et al. (2016) · Frontiers in Microbiology

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 75

Molecular Diversity and Routes of Colonization of Candida albicans in a Surgical Intensive Care Unit, as Studied Using Microsatellite Markers

Stéphan, F., Sialou Bah, M., Desterke, C., Rézaiguia‐Delclaux, S., Foulet, F., Duvaldestin, P., & Bretagne, S. (2002) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 56

Azole Susceptibility Profiles of More than 9,000 Clinical Yeast Isolates Belonging to 40 Common and Rare Species

Desnos-Ollivier, M., Lortholary, O., Bretagne, S., & Dromer, F. (2021) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 44

Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire

Robin, C., Cordonnier, C., Sitbon, K., Raus, N., Lortholary, O., Maury, S., Peffault de la Tour, R., Bretagne, S., & Bastuji-Garin, S. (2019) · Biology of Blood and Marrow Transplantation

Antifungal resistance and susceptibilityHematopoietic Stem Cell Transplantation

Cited by 38

Uniform distribution of three Candida albicans microsatellite markers in two French ICU populations supports a lack of nosocomial cross-contamination

Eloy, O., Marque, S., Botterel, F., Stephan, F., Costa, J.-M., Lasserre, V., & Bretagne, S. (2006) · BMC Infectious Diseases

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 35

High Prevalence of Putative Invasive Pulmonary Aspergillosis in Critically Ill COVID-19 Patients

Alanio, A., Dellière, S., Fodil, S., Bretagne, S., & Mégarbane, B. (2020) · SSRN Electronic Journal

Antifungal resistance and susceptibilityCOVID-19 Clinical Research Studies

Cited by 27

Absence of Fungal Spore Internalization by Bronchial Epithelium in Mouse Models Evidenced by a New Bioimaging Approach and Transmission Electronic Microscopy

Rammaert, B., Jouvion, G., de Chaumont, F., Garcia-Hermoso, D., Szczepaniak, C., Renaudat, C., Olivo-Marin, J.-C., Chrétien, F., Dromer, F., & Bretagne, S. (2015) · The American Journal of Pathology

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 22

Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations

Desnos-Ollivier, M., Bretagne, S., Lortholary, O., Dromer, F., & the French Mycoses Study Group N. Brieu CH Aix, T. C. (2022) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 13